LSERS
PCRX icon

Louisiana State Employees Retirement System’s Pacira BioSciences PCRX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$411K Sell
18,200
-1,500
-8% -$33.3K 0.01% 1404
2025
Q4 		$510K Sell
19,700
-1,000
-5% -$23.8K 0.01% 1352
2025
Q3 		$533K Sell
20,700
-900
-4% -$22.1K 0.01% 1316
2025
Q2 		$516K Sell
21,600
-100
-0.5% -$2.52K 0.01% 1305
2025
Q1 		$539K Sell
21,700
-600
-3% -$14.4K 0.01% 1294
2024
Q4 		$420K Hold
22,300
– – 0.01% 1399
2024
Q3 		$336K Sell
22,300
-1,100
-5% -$18.8K 0.01% 1466
2024
Q2 		$669K Buy
23,400
+400
+2% +$11.4K 0.01% 1217
2024
Q1 		$672K Sell
23,000
-200
-0.9% -$6.14K 0.01% 1221
2023
Q4 		$783K Sell
23,200
-400
-2% -$11.7K 0.02% 1143
2023
Q3 		$724K Sell
23,600
-500
-2% -$18K 0.02% 1103
2023
Q2 		$966K Buy
24,100
+2,700
+13% +$112K 0.02% 921
2023
Q1 		$873K Sell
21,400
-400
-2% -$15.9K 0.02% 908
2022
Q4 		$842K Sell
21,800
-100
-0.5% -$4.87K 0.02% 901
2022
Q3 		$1.17M Sell
21,900
-100
-0.5% -$5.56K 0.03% 618
2022
Q2 		$1.19M Buy
22,000
+300
+1% +$19.7K 0.03% 658
2022
Q1 		$1.63M Buy
21,700
+100
+0.5% +$6.67K 0.04% 514
2021
Q4 		$1.3M Buy
21,600
+200
+0.9% +$11K 0.03% 721
2021
Q3 		$1.2M Buy
21,400
+1,500
+8% +$86.5K 0.03% 745
2021
Q2 		$1.21M Hold
19,900
– – 0.03% 729
2021
Q1 		$1.4M Sell
19,900
-100
-0.5% -$7.14K 0.04% 569
2020
Q4 		$1.2M Buy
20,000
+200
+1% +$11.7K 0.03% 585
2020
Q3 		$1.19M Buy
19,800
+8,380
+73% +$487K 0.05% 406
2020
Q2 		$599K Sell
11,420
-100
-0.9% -$4.18K 0.04% 667
2020
Q1 		$386K Sell
11,520
-2,770
-19% -$115K 0.03% 788
2019
Q4 		$647K Buy
+14,290
New +$607K 0.03% 819

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Louisiana State Employees Retirement System's PCRX Position: Q1 2026 in Review

Louisiana State Employees Retirement System reduced its Pacira BioSciences (PCRX) stake by 7.6% in Q1 2026, selling an estimated $33.3K and leaving 18,200 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #1404.

Louisiana State Employees Retirement System first reported a position in PCRX in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.63M in Q1 2022. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Louisiana State Employees Retirement System held 18,200 shares of Pacira BioSciences worth $411K as of Q1 2026.
  • Louisiana State Employees Retirement System sold 1,500 Pacira BioSciences shares in Q1 2026, an estimated $33.3K.
  • Pacira BioSciences made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q1 2026, its #1404 holding.
  • Louisiana State Employees Retirement System first reported a position in Pacira BioSciences in Q4 2019 and has held it in 26 quarters since.
  • Louisiana State Employees Retirement System's Pacira BioSciences position peaked at $1.63M in Q1 2022.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.